Minerva Neurosciences (NERV) Other financing activities (2014 - 2026)
Minerva Neurosciences posted quarterly Other financing activities of $90875.0 for Q1 2026, down 17.97% on a QoQ basis from $110782.0 in Q4 2025.
Minerva Neurosciences (NERV) has 7 years of Other financing activities data on file, last reported at $90875.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $90875.0; the trailing twelve-month figure through Mar 2026 stood at $288348.0 (changed N/A YoY), and the FY2023 full-year result was $396293.0, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $90875.0, down from $110782.0 in the prior quarter.
- Across five years, Other financing activities topped out at $300000.0 in Q2 2023 and bottomed at $86691.0 in Q3 2023.
- The 3-year median for Other financing activities is $100828.5 (2025), against an average of $147087.0.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90,875.00 |
| Mar 31, 2026 | 90,875.00 |
| Dec 31, 2025 | 110,782.00 |
| Dec 31, 2025 | 110,782.00 |
| Sep 30, 2023 | 86,691.00 |
| Sep 30, 2023 | 86,691.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Sep 30, 2020 | 236,149.00 |
| Sep 30, 2020 | 236,149.00 |
| Sep 30, 2017 | 2.90 Mn |
| Sep 30, 2017 | 2.90 Mn |
| Jun 30, 2017 | -2.96 Mn |
| Jun 30, 2017 | -2.96 Mn |
| Sep 30, 2016 | 156,698.00 |
| Sep 30, 2016 | 156,698.00 |
| Jun 30, 2016 | -124,694.00 |
| Jun 30, 2016 | -124,694.00 |
| Dec 31, 2014 | 30,251.00 |
| Dec 31, 2014 | 30,251.00 |
| Sep 30, 2014 | 3.02 Mn |
| Sep 30, 2014 | 3.02 Mn |
| Mar 31, 2014 | 105,417.00 |
| Mar 31, 2014 | 105,417.00 |